Jupiter Orphan Therapeutics, Inc., a clinical stage pharmaceutical company focused on treating central nervous system (CNS) disorders and rare diseases, today announced a name change to Jupiter Neurosciences, Inc., and a new website, www.jupiterneurosciences.com.
September 14, 2021
· 3 min read